Back to explore
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)
2 Assessments
1 Serious · 0 Some · 1 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV013 Clinical Chair in Health Services Research | 31 Oct 2025 | No | Yes | No | No | No concerns | View |
| RV018 Methods Support Unit Manager | 18 Feb 2026 | No | Yes | No | No | Serious concerns | View |
Publication Details
Journal
BMJ
Publisher
BMJ
Published
29 Oct 2025
ISSN / eISSN
1756-1833